Literature DB >> 7497638

Cholinesterase inhibition: complexities in interpretation.

M Lotti1.   

Abstract

Cholinesterases are measured to assess exposures to or effects of organophosphorus esters and carbamates. Plasma butyrylcholinesterase is usually most sensitive to inhibitors, but it has no known physiological function(s); its inhibition reflects exposure. The physiological function of erythrocyte acetylcholinesterase (AChE) also is not known, but the enzyme is the same as that involved in synaptic transmission and its measurement is used to mirror effects on the nervous system. Erythrocyte AChE has large inter- and intraindividual variation, and small changes are detectable by comparison with preexposure values. The relation between inhibition of erythrocytes and nervous tissue AChE depends on the pharmacokinetics of inhibitors. Usually, erythrocyte AChE inhibition overestimates that in the nervous system. Pharmacodynamic factors such as spontaneous reactivation and aging of inhibited enzyme should also be considered in assessing AChE inhibition. Other factors, such as timing of measurement, add complexity because erythrocyte AChE inhibition persists longer than that in the nervous tissues. Cholinergic transmission might also be impaired because of direct effects of organophosphorus esters and carbamates on receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7497638

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  27 in total

1.  Self reported symptoms and inhibition of acetylcholinesterase activity among Kenyan agricultural workers.

Authors:  G J Ohayo-Mitoko; H Kromhout; J M Simwa; J S Boleij; D Heederik
Journal:  Occup Environ Med       Date:  2000-03       Impact factor: 4.402

Review 2.  Management of acute organophosphorus pesticide poisoning.

Authors:  Darren M Roberts; Cynthia K Aaron
Journal:  BMJ       Date:  2007-03-24

Review 3.  Pharmacodynamic-tolerability relationships of cholinesterase inhibitors for Alzheimer's disease.

Authors:  B P Imbimbo
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

4.  The effect of in vitro homocystinuria on the suckling rat hippocampal acetylcholinesterase.

Authors:  Kleopatra H Schulpis; Konstantinos Kalimeris; Constantinos Bakogiannis; Theodore Tsakiris; Stylianos Tsakiris
Journal:  Metab Brain Dis       Date:  2006-05-06       Impact factor: 3.584

Review 5.  Identification and characterization of biomarkers of organophosphorus exposures in humans.

Authors:  Jerry H Kim; Richard C Stevens; Michael J MacCoss; David R Goodlett; Alex Scherl; Rebecca J Richter; Stephanie M Suzuki; Clement E Furlong
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

6.  Biomonitoring of organophosphorus agent exposure by reactivation of cholinesterase enzyme based on carbon nanotube-enhanced flow-injection amperometric detection.

Authors:  Dan Du; Jun Wang; Jordan N Smith; Charles Timchalk; Yuehe Lin
Journal:  Anal Chem       Date:  2009-11-15       Impact factor: 6.986

7.  Neurobehavioral deficits and increased blood pressure in school-age children prenatally exposed to pesticides.

Authors:  Raul Harari; Jordi Julvez; Katsuyuki Murata; Dana Barr; David C Bellinger; Frodi Debes; Philippe Grandjean
Journal:  Environ Health Perspect       Date:  2010-02-25       Impact factor: 9.031

8.  Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure.

Authors:  André C Affonso; Daniele G Machado; Fernanda Malgarin; Daiane B Fraga; Fernando Ghedim; Alexandra Zugno; Emílio L Streck; Patrícia F Schuck; Gustavo C Ferreira
Journal:  Metab Brain Dis       Date:  2013-03-09       Impact factor: 3.584

Review 9.  Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.

Authors:  Biljana Antonijevic; Milos P Stojiljkovic
Journal:  Clin Med Res       Date:  2007-03

10.  Electrometric measurement of plasma, erythrocyte, and whole blood cholinesterase activities in healthy human volunteers.

Authors:  F K Mohammad; A S Alias; O A H Ahmed
Journal:  J Med Toxicol       Date:  2007-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.